0001209191-23-039176.txt : 20230622
0001209191-23-039176.hdr.sgml : 20230622
20230622193143
ACCESSION NUMBER: 0001209191-23-039176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts Eric W
CENTRAL INDEX KEY: 0001576244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 231034584
MAIL ADDRESS:
STREET 1: VALENCE LIFE SCIENCES LLC
STREET 2: 500 PARK AVENUE 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CalciMedica, Inc.
CENTRAL INDEX KEY: 0001534133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452120079
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-952-5500
MAIL ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: CalciMedica, Inc. /DE/
DATE OF NAME CHANGE: 20230322
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG VISION, INC.
DATE OF NAME CHANGE: 20170717
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG, Inc.
DATE OF NAME CHANGE: 20150303
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-20
0
0001534133
CalciMedica, Inc.
CALC
0001576244
Roberts Eric W
C/O CALCIMEDICA, INC.
505 COAST S. BLVD. #202
LA JOLLA
CA
92037
1
1
1
0
Chief Business Officer
0
Common Stock
2023-06-20
4
P
0
500
4.85
A
13685
I
By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
Common Stock
2023-06-21
4
P
0
2000
4.125
A
15685
I
By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
Common Stock
12187
D
Common Stock
1800
I
By FMTC Custodian - Roth IRA FBO Eric W. Roberts
Common Stock
10661
I
By IRA Financial Trust Company CFBO Eric W. Roberts
Common Stock
356989
I
By Valence Investments SPV IV, LLC
Common Stock
66228
I
By Valence Investments SPV V, LLC
Common Stock
316109
I
By Valence Investments SPV VI, LLC
The weighted average purchase price for the transaction reported was $4.125, and the range of prices were between $3.95 and $4.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of his pecuniary interest therein.
By John Dunn, Attorney-in-Fact
2023-06-22